Surfing the MASH Tsunami

S4-E33.1 - EASL Congress 2023: Focus on New Nomenclature


Listen Later

Send us Fan Mail

Throughout the month of July, Surfing NASH embarks on a series of episodes dedicated to takeaways emerging from a busy past month at both the 2023 EASL Congress and the American Diabetes Association's 83rd Scientific Sessions. For this feature, Sven Francque (University of Antwerp) and Ian Rowe (University of Leeds) join Jörn Schattenberg and Roger Green to discuss a range of fascinating topics to emerge at the EASL Congress meeting held in Vienna.

This conversation focuses on the outcome of the nomenclature process, a three-stage Delphi process that produced new names and classification for what had previously been known as fatty liver disease and henceforth will be known as the steatotic liver disease (SLD). Sven, who was actively involved in the entire exercise, gives a concise summary of the process by which the new classifications were developed and how the new terminology will work. The rest of the conversation focuses on three issues. First, excitement that we will now have the opportunity to study patients whose disease has both metabolic and alcohol-based components. Second, the processes by which the three clinicians, Sven, Ian and Jörn are starting to share the new structure with their patients with varying degrees of success. One interesting observation emerges here from Sven: the English language terms do not translate equally into Dutch, so there is a patient advocate-led effort to create a new set of terms in Dutch. Third, Roger raises concerns about implementation planning for the new nomenclature. One concern is around the possible impact on drug or diagnostic development and the other about the kinds of communication issues covered earlier episodes. Sven, who again worked more closely on the process, states with confidence that the change will not have impact on drug or diagnostic trials. Read more about the switch to steatotic liver disease (SLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) here.

If you have questions or comments around the EASL Congress meeting, new nomenclature, discussed papers or any other topics addressed in this episode, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at [email protected].

Stay Safe and Surf On!


...more
View all episodesView all episodes
Download on the App Store

Surfing the MASH TsunamiBy SurfingNASH.com

  • 3.9
  • 3.9
  • 3.9
  • 3.9
  • 3.9

3.9

24 ratings


More shows like Surfing the MASH Tsunami

View all
Freakonomics Radio by Freakonomics Radio + Stitcher

Freakonomics Radio

32,100 Listeners

Planet Money by NPR

Planet Money

30,666 Listeners

Pivot by New York Magazine

Pivot

9,622 Listeners

DOC Updates by American Diabetes Association

DOC Updates

102 Listeners

The School of Greatness by Lewis Howes

The School of Greatness

21,141 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,360 Listeners

The Daily by The New York Times

The Daily

111,948 Listeners

Up First from NPR by NPR

Up First from NPR

56,508 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,532 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

7,995 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

10,182 Listeners

Consider This from NPR by NPR

Consider This from NPR

6,381 Listeners

EASL Podcasts by European Association for the Study of the Liver

EASL Podcasts

0 Listeners

Docs Who Lift by Docs Who Lift

Docs Who Lift

425 Listeners

The Headlines by The New York Times

The Headlines

736 Listeners